Article

The common neoantigens in colorectal cancer are predicted and validated to be presented or…

medRxiv · 2019 · Liang, Z.; Qin, L.; Chen, L.; Li, W.; Chen, C.; Huang, Y.; Zhang, L.; Liu, S.; Qiu, S.; Ge, Y.; Peng, W.; Lin, X.; Dong, X.; Zhang, X.; Li, B.

Key facts

Title The common neoantigens in colorectal cancer are predicted and validated to be presented or immunogenic
First author Liang, Z.; Qin, L.; Chen, L.; Li, W.; Chen, C.; Huang, Y.; Zhang, L.; Liu, S.; Qiu, S.; Ge, Y.; Peng, W.; Lin, X.; Dong, X.; Zhang, X.; Li, B.
Journal medRxiv
Published Jul 3, 2019
DOI 10.1101/682617
Product codes mentioned MVU, PFT

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature